{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:39:15Z","timestamp":1792118355049,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ohio State University FAME-PRO"},{"name":"Ohio State University Spielman Development Funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00520-019-05211-3","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T06:03:22Z","timestamp":1575612202000},"page":"3669-3677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-6586","authenticated-orcid":false,"given":"Allison M.","family":"Quick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filadelfiya","family":"Zvinovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hundley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvaneswari","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel E.","family":"Reinbolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Bryan","family":"VanDeusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wesolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Stover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Olivia","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar D.","family":"Sardesai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam B.","family":"Lustberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"issue":"4","key":"5211_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","volume":"294","author":"A Pieralli","year":"2016","unstructured":"Pieralli A, Fallani MG, Becorpi A, Bianchi C, Corioni S, Longinotti M, Tredici Z, Guaschino S (2016) Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet 294(4):841\u2013846. https:\/\/doi.org\/10.1007\/s00404-016-4118-6","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"5211_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/gme.0000000000000672","volume":"23","author":"T Pagano","year":"2016","unstructured":"Pagano T, De Rosa P, Vallone R, Schettini F, Arpino G, De Placido S, Nazzaro G, Locci M, De Placido G (2016) Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and\/or hormonal therapy for breast cancer: a retrospective study. Menopause (New York, NY) 23(10):1108\u20131113. https:\/\/doi.org\/10.1097\/gme.0000000000000672","journal-title":"Menopause (New York, NY)"},{"issue":"5","key":"5211_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11912-016-0517-x","volume":"18","author":"SJ Falk","year":"2016","unstructured":"Falk SJ, Bober S (2016) Vaginal health during breast cancer treatment. Curr Oncol Rep 18(5):32. https:\/\/doi.org\/10.1007\/s11912-016-0517-x","journal-title":"Curr Oncol Rep"},{"issue":"12","key":"5211_CR4","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.mayocp.2017.08.019","volume":"92","author":"SS Faubion","year":"2017","unstructured":"Faubion SS, Sood R, Kapoor E (2017) Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc 92(12):1842\u20131849. https:\/\/doi.org\/10.1016\/j.mayocp.2017.08.019","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"5211_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamaoncol.2016.3904","volume":"3","author":"ME Melisko","year":"2017","unstructured":"Melisko ME, Goldman ME, Hwang J, De Luca A, Fang S, Esserman LJ, Chien AJ, Park JW, Rugo HS (2017) Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial. JAMA Oncol 3(3):313\u2013319. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3904","journal-title":"JAMA Oncol"},{"issue":"12","key":"5211_CR6","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1111\/jsm.12684","volume":"11","author":"LR Schover","year":"2014","unstructured":"Schover LR, Baum GP, Fuson LA, Brewster A, Melhem-Bertrandt A (2014) Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med 11(12):3102\u20133111. https:\/\/doi.org\/10.1111\/jsm.12684","journal-title":"J Sex Med"},{"issue":"6","key":"5211_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/gme.0000000000001121","volume":"25","author":"SS Faubion","year":"2018","unstructured":"Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA (2018) Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause (New York, NY) 25(6):596\u2013608. https:\/\/doi.org\/10.1097\/gme.0000000000001121","journal-title":"Menopause (New York, NY)"},{"issue":"2","key":"5211_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00520-017-3878-2","volume":"26","author":"DL Barton","year":"2018","unstructured":"Barton DL, Sloan JA, Shuster LT, Gill P, Griffin P, Flynn K, Terstriep SA, Rana FN, Dockter T, Atherton PJ, Tsai M, Sturtz K, Lafky JM, Riepl M, Thielen J, Loprinzi CL (2018) Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer 26(2):643\u2013650. https:\/\/doi.org\/10.1007\/s00520-017-3878-2","journal-title":"Support Care Cancer"},{"issue":"4","key":"5211_CR9","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00520-017-3960-9","volume":"26","author":"DL Barton","year":"2018","unstructured":"Barton DL, Shuster LT, Dockter T, Atherton PJ, Thielen J, Birrell SN, Sood R, Griffin P, Terstriep SA, Mattar B, Lafky JM, Loprinzi CLJSCC (2018) Systemic and local effects of vaginal dehydroepiandrosterone (DHEA). NCCTG N10C1 (Alliance) 26(4):1335\u20131343. https:\/\/doi.org\/10.1007\/s00520-017-3960-9","journal-title":"NCCTG N10C1 (Alliance)"},{"key":"5211_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11764-017-0606-3","volume":"11","author":"P Advani","year":"2017","unstructured":"Advani P, Brewster AM, Baum GP, Schover LR (2017) A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy. J Cancer Surviv 11:477\u2013485. https:\/\/doi.org\/10.1007\/s11764-017-0606-3","journal-title":"J Cancer Surviv"},{"issue":"6","key":"5211_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/gco.0000000000000230","volume":"27","author":"S Stefano","year":"2015","unstructured":"Stefano S, Stavros A, Massimo C (2015) The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy. Curr Opin Obstet Gynecol 27(6):504\u2013508. https:\/\/doi.org\/10.1097\/gco.0000000000000230","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"5211_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.maturitas.2014.12.006","volume":"80","author":"A Perino","year":"2015","unstructured":"Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, Saitta S, Calagna G (2015) Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas 80(3):296\u2013301. https:\/\/doi.org\/10.1016\/j.maturitas.2014.12.006","journal-title":"Maturitas"},{"issue":"10","key":"5211_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/gme.0000000000000700","volume":"23","author":"ER Sokol","year":"2016","unstructured":"Sokol ER, Karram MM (2016) An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause (New York, NY) 23(10):1102\u20131107. https:\/\/doi.org\/10.1097\/gme.0000000000000700","journal-title":"Menopause (New York, NY)"},{"key":"5211_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.maturitas.2016.09.012","volume":"94","author":"E Pitsouni","year":"2016","unstructured":"Pitsouni E, Grigoriadis T, Tsiveleka A, Zacharakis D, Salvatore S, Athanasiou S (2016) Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study. Maturitas 94:131\u2013136. https:\/\/doi.org\/10.1016\/j.maturitas.2016.09.012","journal-title":"Maturitas"},{"issue":"4","key":"5211_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/13697137.2014.899347","volume":"17","author":"S Salvatore","year":"2014","unstructured":"Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U (2014) A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 17(4):363\u2013369. https:\/\/doi.org\/10.3109\/13697137.2014.899347","journal-title":"Climacteric"},{"key":"5211_CR16","doi-asserted-by":"publisher","unstructured":"Athanasiou S, Pitsouni E, Grigoriadis T, Zacharakis D, Falagas ME, Salvatore S, Protopapas A, Loutradis D (2018) Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results. Menopause (New York, NY). https:\/\/doi.org\/10.1097\/gme.0000000000001206","DOI":"10.1097\/gme.0000000000001206"},{"key":"5211_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejogrb.2017.03.036","volume":"213","author":"F Behnia-Willison","year":"2017","unstructured":"Behnia-Willison F, Sarraf S, Miller J, Mohamadi B, Care AS, Lam A, Willison N, Behnia L, Salvatore S (2017) Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol 213:39\u201344. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.03.036","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5211_CR18","doi-asserted-by":"publisher","unstructured":"Paraiso MFR, Ferrando CA, Sokol ER, Rardin CR, Matthews CA, Karram MM, Iglesia CB (2019) A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial. Menopause (New York, NY). https:\/\/doi.org\/10.1097\/gme.0000000000001416","DOI":"10.1097\/gme.0000000000001416"},{"key":"5211_CR19","doi-asserted-by":"publisher","unstructured":"Pagano T, De Rosa P, Vallone R, Schettini F, Arpino G, Giuliano M, Lauria R, De Santo I, Conforti A, Gallo A, Nazzaro G, De Placido S, Locci M, De Placido G (2017) Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Menopause (New York, NY). https:\/\/doi.org\/10.1097\/gme.0000000000001053","DOI":"10.1097\/gme.0000000000001053"},{"key":"5211_CR20","doi-asserted-by":"publisher","unstructured":"Becorpi A, Campisciano G, Zanotta N, Tredici Z, Guaschino S, Petraglia F, Pieralli A, Sisti G, De Seta F, Comar MJ, Li MS (2018) Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects. 33(5):1047\u20131054. https:\/\/doi.org\/10.1007\/s10103-018-2471-3","DOI":"10.1007\/s10103-018-2471-3"},{"issue":"3","key":"5211_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1200\/jco.2002.20.3.751","volume":"20","author":"J Geisler","year":"2002","unstructured":"Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE (2002) Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 20(3):751\u2013757. https:\/\/doi.org\/10.1200\/jco.2002.20.3.751","journal-title":"J Clin Oncol"},{"key":"5211_CR22","doi-asserted-by":"publisher","unstructured":"Sokol ER, Karram MM (2017) Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Menopause (New York, NY). https:\/\/doi.org\/10.1097\/gme.0000000000000839","DOI":"10.1097\/gme.0000000000000839"},{"issue":"2","key":"5211_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11764-016-0585-9","volume":"11","author":"J Carter","year":"2017","unstructured":"Carter J, Stabile C, Seidel B, Baser RE, Goldfarb S, Goldfrank DJ (2017) Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors. J Cancer Surviv 11(2):274\u2013283. https:\/\/doi.org\/10.1007\/s11764-016-0585-9","journal-title":"J Cancer Surviv"},{"issue":"1","key":"5211_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jsxm.2016.11.317","volume":"14","author":"AA Eaton","year":"2017","unstructured":"Eaton AA, Baser RE, Seidel B, Stabile C, Canty JP, Goldfrank DJ, Carter J (2017) Validation of clinical tools for vaginal and vulvar symptom assessment in cancer patients and survivors. J Sex Med 14(1):144\u2013151. https:\/\/doi.org\/10.1016\/j.jsxm.2016.11.317","journal-title":"J Sex Med"},{"issue":"2","key":"5211_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597","volume":"26","author":"R Rosen","year":"2000","unstructured":"Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191\u2013208. https:\/\/doi.org\/10.1080\/009262300278597","journal-title":"J Sex Marital Ther"},{"issue":"9","key":"5211_CR26","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00520-015-2623-y","volume":"23","author":"I Bartula","year":"2015","unstructured":"Bartula I, Sherman KA (2015) The female sexual functioning index (FSFI): evaluation of acceptability, reliability, and validity in women with breast cancer. Support Care Cancer 23(9):2633\u20132641. https:\/\/doi.org\/10.1007\/s00520-015-2623-y","journal-title":"Support Care Cancer"},{"issue":"2","key":"5211_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/nau.1930140206","volume":"14","author":"JS Uebersax","year":"1995","unstructured":"Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA (1995) Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Continence program for women research group. Neurourol Urodyn 14(2):131\u2013139","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"5211_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000445074","volume":"82","author":"MA Weber","year":"2017","unstructured":"Weber MA, Lim V, Oryszczyn J, Te West N, Souget J, Jeffery S, Roovers JP, Moore KH (2017) The effect of vaginal oestriol cream on subjective and objective symptoms of stress urinary incontinence and vaginal atrophy: an international multi-centre pilot study. Gynecol Obstet Investig 82(1):15\u201321. https:\/\/doi.org\/10.1159\/000445074","journal-title":"Gynecol Obstet Investig"},{"issue":"1","key":"5211_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1067\/mob.2003.379","volume":"189","author":"I Yalcin","year":"2003","unstructured":"Yalcin I, Bump RC (2003) Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 189(1):98\u2013101","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"5211_CR30","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/jc.2015-2236","volume":"100","author":"CA Stuenkel","year":"2015","unstructured":"Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ (2015) Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100(11):3975\u20134011. https:\/\/doi.org\/10.1210\/jc.2015-2236","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5211_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/annonc\/mdj127","volume":"17","author":"A Kendall","year":"2006","unstructured":"Kendall A, Dowsett M, Folkerd E, Smith I (2006) Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 17(4):584\u2013587. https:\/\/doi.org\/10.1093\/annonc\/mdj127","journal-title":"Ann Oncol"},{"key":"5211_CR32","doi-asserted-by":"publisher","unstructured":"Biglia N, Bounous VE, D'Alonzo M, Ottino L, Tuninetti V, Robba E, Perrone T (2017) Vaginal atrophy in breast cancer survivors: attitude and approaches among oncologists. Clin Breast Cancer. https:\/\/doi.org\/10.1016\/j.clbc.2017.05.008","DOI":"10.1016\/j.clbc.2017.05.008"},{"issue":"3","key":"5211_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","volume":"100","author":"D Cella","year":"2006","unstructured":"Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A (2006) Quality of life of postmenopausal women in the ATAC (\u201cArimidex\u201d, tamoxifen, alone or in combination) trial after completion of 5 years\u2019 adjuvant treatment for early breast cancer. Breast Cancer Res Treat 100(3):273\u2013284. https:\/\/doi.org\/10.1007\/s10549-006-9260-6","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5211_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-016-3827-7","volume":"157","author":"E Sulaica","year":"2016","unstructured":"Sulaica E, Han T, Wang W, Bhat R, Trivedi MV, Niravath P (2016) Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy. Breast Cancer Res Treat 157(2):203\u2013210. https:\/\/doi.org\/10.1007\/s10549-016-3827-7","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5211_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","volume":"126","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, Kwan M, Gomez SL, Neugut AI (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126(2):529\u2013537. https:\/\/doi.org\/10.1007\/s10549-010-1132-4","journal-title":"Breast Cancer Res Treat"},{"key":"5211_CR36","doi-asserted-by":"publisher","unstructured":"Pagani O, Francis PA, Fleming GF, Walley BA, Viale G, Colleoni M, Lang I, Gomez HL, Tondini C, Pinotti G, Di Leo A, Coates AS, Goldhirsch A, Gelber RD, Regan MM (2019) Absolute improvements in freedom from distant recurrence to tailor adjuvant endocrine therapies for premenopausal women: results from TEXT and SOFT. J Clin Oncol. https:\/\/doi.org\/10.1200\/jco.18.01967","DOI":"10.1200\/jco.18.01967"},{"issue":"2","key":"5211_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/lsm.22569","volume":"49","author":"A Gaspar","year":"2017","unstructured":"Gaspar A, Brandi H, Gomez V, Luque D (2017) Efficacy of erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med 49(2):160\u2013168. https:\/\/doi.org\/10.1002\/lsm.22569","journal-title":"Lasers Surg Med"},{"issue":"6","key":"5211_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.clbc.2015.06.012","volume":"15","author":"TK Kallak","year":"2015","unstructured":"Kallak TK, Baumgart J, Nilsson K, Akerud H, Poromaa IS, Stavreus-Evers A (2015) Vaginal gene expression during treatment with aromatase inhibitors. Clin Breast Cancer 15(6):527\u2013535.e522. https:\/\/doi.org\/10.1016\/j.clbc.2015.06.012","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"5211_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/13697137.2014.975197","volume":"18","author":"S Salvatore","year":"2015","unstructured":"Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U (2015) Sexual function after fractional microablative CO(2) laser in women with vulvovaginal atrophy. Climacteric 18(2):219\u2013225. https:\/\/doi.org\/10.3109\/13697137.2014.975197","journal-title":"Climacteric"},{"issue":"4","key":"5211_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/gme.0000000000001293","volume":"26","author":"C Gordon","year":"2019","unstructured":"Gordon C, Gonzales S, Krychman ML (2019) Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy. Menopause (New York, NY) 26(4):423\u2013427. https:\/\/doi.org\/10.1097\/gme.0000000000001293","journal-title":"Menopause (New York, NY)"},{"issue":"18","key":"5211_CR41","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1002\/cncr.26739","volume":"118","author":"RE Baser","year":"2012","unstructured":"Baser RE, Li Y, Carter J (2012) Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer 118(18):4606\u20134618. https:\/\/doi.org\/10.1002\/cncr.26739","journal-title":"Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-05211-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T19:32:44Z","timestamp":1607110364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-05211-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["5211"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-05211-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"assertion":[{"value":"8 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No financial support was provided by Hologic inc. The laser devise was provided by loan to OSU from Hologic\/Cynosure. None of the investigators received financial support from Hologic\/Cynosure. The company was not involved in study data analysis or manuscript preparation. The corresponding author has full control of the primary data and can be reviewed by the journal if requested.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}